We're pleased to announce that Biotome has filed a provisional patent for our novel peptide modification technology that dramatically increases ELISA sensitivity without the complexity and costs of traditional conjugation methods.

Biotome will join the Australian delegation at the BIO International Convention in Boston, June 16-19, 2025. This is our first major US biotechnology conference – and we're ready to connect.

Biotome is pleased to announce the arrival of our first prototype diagnostic test kits from manufacturing partner Biosensis Pty Ltd. These kits represent the culmination of years of research into precision detection of high-virulence Helicobacter pylori strains that significantly elevate gastric cancer risk.

Perth, Western Australia - July 2, 2024: - Biotome Pty Ltd , a Western Australian biotechnology company, has been awarded an Innovation Booster Grant from the Western Australian Government's New Industries Fund . This grant will support the development and international patenting of Biotome's innovative preeclampsia risk test. The test, which uses novel peptide targets to detect specific antibodies in the blood, aims to provide early risk assessment for preeclampsia, a condi

October, 2022 - Perth, Australia: Biotome has installed the first LiCor Odyssey M multimodal imager in Australia. The new imager fills a critical role in their ongoing project to help develop and validate a rapid diagnostic test for sepsis. The scanner is capable of scanning 18 imaging channels, including near-infrared and visible fluorescence, bioluminescence and chemiluminescence, and RGB true colour. Thanks to its line confocal scanning system with sCMOS sensor technology

Thursday, September 14th, 2022 - Perth, Australia: Biotome is part of an international consortium that has been awarded a grant from the Leducq Foundation for the Acute Rheumatic Fever Diagnosis Collaborative Network (ARC Network). The goal of this project is to discover biomarkers that accurately identify patients with acute rheumatic fever. Acute rheumatic fever [ARF] is a serious complication following a strep throat infection caused by Group A Streptococcus bacteria. It

Thursday, August 25th, 2022 - Perth, Australia: Biotome has been granted US Patent No. 11,401,308 covering the use of peptides that can detect CagA+ Helicobacter pylori infection for use in diagnostics. Diagnostics using these peptides can identify individuals with carcinogenic CagA+ H. pylori infection, which is a major risk factor for developing stomach cancer. The patented peptides offer significant advantages over existing antigen-based methods as they target specific a

Tuesday, July 5th, 2022 - Perth, Australia: Biotome has been awarded $497,000 in funding from the Western Australian Future Health Research & Innovation Fund , to develop their precision diagnostic for stomach cancer risk. This test will be the world’s first diagnostic for stomach cancer risk with high enough accuracy and a low enough cost to be used for public health screening. It has the potential to save thousands of lives in Australia, and millions around the world. Biot

Perth, Australia – May 4, 2021 - Precision diagnostics company Biotome Pty Ltd has entered into a technology partnership with Cardea Bio Inc , a global leader in nanoelectronics manufacturing and the only mass-producer of graphene-based biological transistors. Through Biotome joining Cardea’s Innovation Partnership Program, the companies can work together to leverage Cardea’s proprietary Cardean Transistor™ technology for the development of electrochemical biosensors for pr

Perth, Australia April 5, 2021 – BrainChip Holdings Ltd (ASX: BRN), a leading provider of ultra-low power high performance artificial intelligence technology, today announced that the Brainchip Research Institute in Perth has entered into a research collaboration with precision immunology company Biotome Pty Ltd. Biotome is developing highly accurate antibody tests for infections. The Akida neuromorphic processor chip will be used to interpret sensor responses and to find ou